NCT00012311 Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer Status UNKNOWN Phase PHASE2
NCT00012298 Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE1/PHASE2
NCT00012051 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE3
NCT00011921 Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer Status UNKNOWN Phase PHASE3
NCT00010413 Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus Status COMPLETED Phase PHASE2
NCT00010400 Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome Status COMPLETED Phase NA
NCT00010387 Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease Status COMPLETED Phase PHASE2
NCT00009880 Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach Status COMPLETED Phase PHASE2
NCT00009763 Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer Status UNKNOWN Phase PHASE1
NCT00009750 Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Status UNKNOWN Phase PHASE1
NCT00008268 Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT00008229 Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT00008190 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia Status COMPLETED Phase PHASE2
NCT00008125 Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00008021 Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma Status UNKNOWN Phase PHASE1
NCT00008008 Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma Status COMPLETED Phase PHASE2
NCT00007995 Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis Status COMPLETED Phase PHASE2
NCT00007982 Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer Status COMPLETED Phase PHASE2
NCT00007904 Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes Status COMPLETED Phase PHASE2
NCT00007891 Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1